Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asymmetric Unit
(-)Asym. Unit - sites
(-)Biological Unit 1
(-)Biol. Unit 1 - sites
(-)Biological Unit 2
collapse expand < >
Image Asymmetric Unit
Asymmetric Unit  (Jmol Viewer)
Image Asym. Unit - sites
Asym. Unit - sites  (Jmol Viewer)
Image Biological Unit 1
Biological Unit 1  (Jmol Viewer)
Image Biol. Unit 1 - sites
Biol. Unit 1 - sites  (Jmol Viewer)
Image Biological Unit 2
Biological Unit 2  (Jmol Viewer)

(-) Description

Title :  CRYSTAL STRUCTURE OF FGF1 COMPLEXED WITH THE ECTODOMAIN OF FGFR1C EXHIBITING AN ORDERED LIGAND SPECIFICITY-DETERMINING BETAC'-BETAE LOOP
 
Authors :  A. Beenken, M. Mohammadi
Date :  23 Aug 10  (Deposition) - 28 Dec 11  (Release) - 07 Mar 12  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  2.60
Chains :  Asym. Unit :  A,B,C,D
Biol. Unit 1:  A,C  (1x)
Biol. Unit 2:  B,D  (1x)
Keywords :  Beta Trefoil Motif, Immunoglobulin-Like Domain, Growth Factor, Growth Factor Receptor, Extracellular, Cytokine-Signaling Protein Complex (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  A. Beenken, A. V. Eliseenkova, O. A. Ibrahimi, S. K. Olsen, M. Mohammad
Plasticity In Interactions Of Fibroblast Growth Factor 1 (Fgf1) N Terminus With Fgf Receptors Underlies Promiscuity Of Fgf1.
J. Biol. Chem. V. 287 3067 2012
PubMed-ID: 22057274  |  Reference-DOI: 10.1074/JBC.M111.275891

(-) Compounds

Molecule 1 - HEPARIN-BINDING GROWTH FACTOR 1
    ChainsA, B
    EngineeredYES
    Expression SystemESCHERICHIA COLI
    Expression System StrainBL21 DE3
    Expression System Taxid562
    Expression System Vector TypePLASMID
    GeneFGF1, FGFA
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymHBGF-1, ACIDIC FIBROBLAST GROWTH FACTOR, AFGF, BETA- ENDOTHELIAL CELL GROWTH FACTOR, ECGF-BETA
 
Molecule 2 - BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1
    ChainsC, D
    EC Number2.7.10.1
    EngineeredYES
    Expression SystemESCHERICHIA COLI
    Expression System PlasmidPET28A
    Expression System StrainBL21 DE3
    Expression System Taxid562
    Expression System Vector TypePLASMID
    FragmentFGFR1C
    GeneFGFBR, FGFR1, FLG, FLT2
    MutationYES
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymBFGF-R-1, FGFR-1, PROTO-ONCOGENE C-FGR, FMS-LIKE TYROSINE KINASE 2, FLT-2

 Structural Features

(-) Chains, Units

  1234
Asymmetric Unit ABCD
Biological Unit 1 (1x)A C 
Biological Unit 2 (1x) B D

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (3, 6)

Asymmetric Unit (3, 6)
No.NameCountTypeFull Name
1IDS2Ligand/Ion2-O-SULFO-ALPHA-L-IDOPYRANURONIC ACID
2SGN3Ligand/IonN,O6-DISULFO-GLUCOSAMINE
3UAP1Ligand/Ion1,4-DIDEOXY-5-DEHYDRO-O2-SULFO-GLUCURONIC ACID
Biological Unit 1 (3, 6)
No.NameCountTypeFull Name
1IDS2Ligand/Ion2-O-SULFO-ALPHA-L-IDOPYRANURONIC ACID
2SGN3Ligand/IonN,O6-DISULFO-GLUCOSAMINE
3UAP1Ligand/Ion1,4-DIDEOXY-5-DEHYDRO-O2-SULFO-GLUCURONIC ACID
Biological Unit 2 (0, 0)
No.NameCountTypeFull Name
1IDS-1Ligand/Ion2-O-SULFO-ALPHA-L-IDOPYRANURONIC ACID
2SGN-1Ligand/IonN,O6-DISULFO-GLUCOSAMINE
3UAP-1Ligand/Ion1,4-DIDEOXY-5-DEHYDRO-O2-SULFO-GLUCURONIC ACID

(-) Sites  (6, 6)

Asymmetric Unit (6, 6)
No.NameEvidenceResiduesDescription
1AC1SOFTWARELYS A:143 , SGN A:302BINDING SITE FOR RESIDUE UAP A 301
2AC2SOFTWAREASN A:33 , LYS A:128 , LYS A:133 , GLN A:142 , LYS A:143 , ALA A:144 , UAP A:301 , IDS A:303 , ARG B:137BINDING SITE FOR RESIDUE SGN A 302
3AC3SOFTWAREASN A:33 , LYS A:127 , LYS A:128 , LYS A:133 , SGN A:302 , SGN A:304BINDING SITE FOR RESIDUE IDS A 303
4AC4SOFTWARELYS A:128 , ASN A:129 , IDS A:303 , IDS A:305 , LYS B:127 , LYS B:128 , LYS B:133BINDING SITE FOR RESIDUE SGN A 304
5AC5SOFTWARESGN A:304 , SGN A:306 , ASN B:33 , LYS B:128 , LYS B:133 , GLN B:142 , LYS B:143 , ALA B:144BINDING SITE FOR RESIDUE IDS A 305
6AC6SOFTWAREIDS A:305 , LYS B:128 , LYS B:143BINDING SITE FOR RESIDUE SGN A 306

(-) SS Bonds  (4, 4)

Asymmetric Unit
No.Residues
1C:178 -C:230
2C:277 -C:341
3D:178 -D:230
4D:277 -D:341

(-) Cis Peptide Bonds  (4, 4)

Asymmetric Unit
No.Residues
1Thr C:183 -Pro C:184
2Leu C:261 -Pro C:262
3Thr D:183 -Pro D:184
4Leu D:261 -Pro D:262

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (31, 62)

Asymmetric Unit (31, 62)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_021357G21EFGF1_HUMANPolymorphism17223632A/BG21E
02UniProtVAR_070851L165SFGFR1_HUMANDisease (HRTFDS)397515481C/DL165S
03UniProtVAR_017887A167SFGFR1_HUMANDisease (HH2)121909630C/DA167S
04UniProtVAR_072995V174AFGFR1_HUMANDisease (HH2)  ---C/DV174A
05UniProtVAR_030974C178SFGFR1_HUMANDisease (HH2)  ---C/DC178S
06UniProtVAR_070852L191SFGFR1_HUMANDisease (HRTFDS)869025669C/DL191S
07UniProtVAR_030975W213GFGFR1_HUMANPolymorphism17851623C/DW213G
08UniProtVAR_030976D224HFGFR1_HUMANDisease (HH2)  ---C/DD224H
09UniProtVAR_069289Y228DFGFR1_HUMANDisease (HH2)  ---C/DY228D
10UniProtVAR_030977G237DFGFR1_HUMANDisease (HH2)  ---C/DG237D
11UniProtVAR_030978G237SFGFR1_HUMANDisease (HH2)121909635C/DG237S
12UniProtVAR_069290I239TFGFR1_HUMANDisease (HH2)  ---C/DI239T
13UniProtVAR_030979L245PFGFR1_HUMANDisease (HH2)  ---C/DL245P
14UniProtVAR_069291R250QFGFR1_HUMANDisease (HH2)121909645C/DR250Q
15UniProtVAR_030980R250WFGFR1_HUMANDisease (HH2)  ---C/DR250W
16UniProtVAR_004111P252RFGFR1_HUMANDisease (PS)121909627C/DP252R
17UniProtVAR_042202P252TFGFR1_HUMANUnclassified121913472C/DP252T
18UniProtVAR_030981R254QFGFR1_HUMANDisease (HH2)  ---C/DR254Q
19UniProtVAR_030982G270DFGFR1_HUMANDisease (HH2)  ---C/DG270D
20UniProtVAR_030983V273MFGFR1_HUMANDisease (HH2)  ---C/DV273M
21UniProtVAR_030984E274GFGFR1_HUMANDisease (HH2)727505369C/DE274G
22UniProtVAR_017888C277YFGFR1_HUMANDisease (HH2)  ---C/DC277Y
23UniProtVAR_030985P283RFGFR1_HUMANDisease (HH2)  ---C/DP283R
24UniProtVAR_030986I300TFGFR1_HUMANDisease (TRIGNO1)121909633C/DI300T
25UniProtVAR_030987N330IFGFR1_HUMANDisease (OGD)121909632C/DN330I
26UniProtVAR_030988S332CFGFR1_HUMANDisease (HH2)  ---C/DS332C
27UniProtVAR_030989Y339CFGFR1_HUMANDisease (HH2)  ---C/DY339C
28UniProtVAR_069954L342SFGFR1_HUMANDisease (HH2)121909638C/DL342S
29UniProtVAR_030990A343VFGFR1_HUMANDisease (HH2)  ---C/DA343V
30UniProtVAR_030991S346CFGFR1_HUMANDisease (HH2)  ---C/DS346C
31UniProtVAR_069955G348RFGFR1_HUMANDisease (HH2)  ---C/DG348R

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 1 (31, 31)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_021357G21EFGF1_HUMANPolymorphism17223632AG21E
02UniProtVAR_070851L165SFGFR1_HUMANDisease (HRTFDS)397515481CL165S
03UniProtVAR_017887A167SFGFR1_HUMANDisease (HH2)121909630CA167S
04UniProtVAR_072995V174AFGFR1_HUMANDisease (HH2)  ---CV174A
05UniProtVAR_030974C178SFGFR1_HUMANDisease (HH2)  ---CC178S
06UniProtVAR_070852L191SFGFR1_HUMANDisease (HRTFDS)869025669CL191S
07UniProtVAR_030975W213GFGFR1_HUMANPolymorphism17851623CW213G
08UniProtVAR_030976D224HFGFR1_HUMANDisease (HH2)  ---CD224H
09UniProtVAR_069289Y228DFGFR1_HUMANDisease (HH2)  ---CY228D
10UniProtVAR_030977G237DFGFR1_HUMANDisease (HH2)  ---CG237D
11UniProtVAR_030978G237SFGFR1_HUMANDisease (HH2)121909635CG237S
12UniProtVAR_069290I239TFGFR1_HUMANDisease (HH2)  ---CI239T
13UniProtVAR_030979L245PFGFR1_HUMANDisease (HH2)  ---CL245P
14UniProtVAR_069291R250QFGFR1_HUMANDisease (HH2)121909645CR250Q
15UniProtVAR_030980R250WFGFR1_HUMANDisease (HH2)  ---CR250W
16UniProtVAR_004111P252RFGFR1_HUMANDisease (PS)121909627CP252R
17UniProtVAR_042202P252TFGFR1_HUMANUnclassified121913472CP252T
18UniProtVAR_030981R254QFGFR1_HUMANDisease (HH2)  ---CR254Q
19UniProtVAR_030982G270DFGFR1_HUMANDisease (HH2)  ---CG270D
20UniProtVAR_030983V273MFGFR1_HUMANDisease (HH2)  ---CV273M
21UniProtVAR_030984E274GFGFR1_HUMANDisease (HH2)727505369CE274G
22UniProtVAR_017888C277YFGFR1_HUMANDisease (HH2)  ---CC277Y
23UniProtVAR_030985P283RFGFR1_HUMANDisease (HH2)  ---CP283R
24UniProtVAR_030986I300TFGFR1_HUMANDisease (TRIGNO1)121909633CI300T
25UniProtVAR_030987N330IFGFR1_HUMANDisease (OGD)121909632CN330I
26UniProtVAR_030988S332CFGFR1_HUMANDisease (HH2)  ---CS332C
27UniProtVAR_030989Y339CFGFR1_HUMANDisease (HH2)  ---CY339C
28UniProtVAR_069954L342SFGFR1_HUMANDisease (HH2)121909638CL342S
29UniProtVAR_030990A343VFGFR1_HUMANDisease (HH2)  ---CA343V
30UniProtVAR_030991S346CFGFR1_HUMANDisease (HH2)  ---CS346C
31UniProtVAR_069955G348RFGFR1_HUMANDisease (HH2)  ---CG348R

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 2 (31, 31)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_021357G21EFGF1_HUMANPolymorphism17223632BG21E
02UniProtVAR_070851L165SFGFR1_HUMANDisease (HRTFDS)397515481DL165S
03UniProtVAR_017887A167SFGFR1_HUMANDisease (HH2)121909630DA167S
04UniProtVAR_072995V174AFGFR1_HUMANDisease (HH2)  ---DV174A
05UniProtVAR_030974C178SFGFR1_HUMANDisease (HH2)  ---DC178S
06UniProtVAR_070852L191SFGFR1_HUMANDisease (HRTFDS)869025669DL191S
07UniProtVAR_030975W213GFGFR1_HUMANPolymorphism17851623DW213G
08UniProtVAR_030976D224HFGFR1_HUMANDisease (HH2)  ---DD224H
09UniProtVAR_069289Y228DFGFR1_HUMANDisease (HH2)  ---DY228D
10UniProtVAR_030977G237DFGFR1_HUMANDisease (HH2)  ---DG237D
11UniProtVAR_030978G237SFGFR1_HUMANDisease (HH2)121909635DG237S
12UniProtVAR_069290I239TFGFR1_HUMANDisease (HH2)  ---DI239T
13UniProtVAR_030979L245PFGFR1_HUMANDisease (HH2)  ---DL245P
14UniProtVAR_069291R250QFGFR1_HUMANDisease (HH2)121909645DR250Q
15UniProtVAR_030980R250WFGFR1_HUMANDisease (HH2)  ---DR250W
16UniProtVAR_004111P252RFGFR1_HUMANDisease (PS)121909627DP252R
17UniProtVAR_042202P252TFGFR1_HUMANUnclassified121913472DP252T
18UniProtVAR_030981R254QFGFR1_HUMANDisease (HH2)  ---DR254Q
19UniProtVAR_030982G270DFGFR1_HUMANDisease (HH2)  ---DG270D
20UniProtVAR_030983V273MFGFR1_HUMANDisease (HH2)  ---DV273M
21UniProtVAR_030984E274GFGFR1_HUMANDisease (HH2)727505369DE274G
22UniProtVAR_017888C277YFGFR1_HUMANDisease (HH2)  ---DC277Y
23UniProtVAR_030985P283RFGFR1_HUMANDisease (HH2)  ---DP283R
24UniProtVAR_030986I300TFGFR1_HUMANDisease (TRIGNO1)121909633DI300T
25UniProtVAR_030987N330IFGFR1_HUMANDisease (OGD)121909632DN330I
26UniProtVAR_030988S332CFGFR1_HUMANDisease (HH2)  ---DS332C
27UniProtVAR_030989Y339CFGFR1_HUMANDisease (HH2)  ---DY339C
28UniProtVAR_069954L342SFGFR1_HUMANDisease (HH2)121909638DL342S
29UniProtVAR_030990A343VFGFR1_HUMANDisease (HH2)  ---DA343V
30UniProtVAR_030991S346CFGFR1_HUMANDisease (HH2)  ---DS346C
31UniProtVAR_069955G348RFGFR1_HUMANDisease (HH2)  ---DG348R

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (1, 2)

Asymmetric Unit (1, 2)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1HBGF_FGFPS00247 HBGF/FGF family signature.FGF1_HUMAN86-109
 
  2A:86-109
B:86-109
Biological Unit 1 (1, 1)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1HBGF_FGFPS00247 HBGF/FGF family signature.FGF1_HUMAN86-109
 
  1A:86-109
-
Biological Unit 2 (1, 1)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1HBGF_FGFPS00247 HBGF/FGF family signature.FGF1_HUMAN86-109
 
  1-
B:86-109

(-) Exons   (3, 6)

Asymmetric Unit (3, 6)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.3ENST000003780463ENSE00001476010chr5:142065237-142065079159FGF1_HUMAN-00--
1.8bENST000003780468bENSE00002155500chr5:141993726-141993524203FGF1_HUMAN1-57572A:21-57
B:21-57
37
37
1.9bENST000003780469bENSE00000766692chr5:141980370-141980267104FGF1_HUMAN57-91352A:57-91
B:57-91
35
35
1.10fENST0000037804610fENSE00001476009chr5:141975049-1419729342116FGF1_HUMAN92-155642A:92-153
B:92-153
62
62

(-) Sequences/Alignments

Asymmetric Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:133
 aligned with FGF1_HUMAN | P05230 from UniProtKB/Swiss-Prot  Length:155

    Alignment length:133
                                    30        40        50        60        70        80        90       100       110       120       130       140       150   
           FGF1_HUMAN    21 GNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVS 153
               SCOP domains d3ojva_ A: Acidic FGF (FGF1)                                                                                                          SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .......eeee.....eeee.....eeee.........eeeeeee..eeeeee.....eeee.....eeee...hhhh.eeeee.....eeeee...................hhhhh........eeee... Sec.struct. author
                 SAPs(SNPs) E------------------------------------------------------------------------------------------------------------------------------------ SAPs(SNPs)
                    PROSITE -----------------------------------------------------------------HBGF_FGF  PDB: A:86-109 -------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.8b  PDB: A:21-57 UniProt: 1-57----------------------------------Exon 1.10f  PDB: A:92-153 UniProt: 92-155 [INCOMPLETE]         Transcript 1 (1)
           Transcript 1 (2) ------------------------------------Exon 1.9b  PDB: A:57-91            -------------------------------------------------------------- Transcript 1 (2)
                 3ojv A  21 GNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVS 153
                                    30        40        50        60        70        80        90       100       110       120       130       140       150   

Chain B from PDB  Type:PROTEIN  Length:133
 aligned with FGF1_HUMAN | P05230 from UniProtKB/Swiss-Prot  Length:155

    Alignment length:133
                                    30        40        50        60        70        80        90       100       110       120       130       140       150   
           FGF1_HUMAN    21 GNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVS 153
               SCOP domains d3ojvb_ B: Acidic FGF (FGF1)                                                                                                          SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .......eeee.....eeee.....eeee.........eeeeeee..eeeeee.....eeee.....eeee...hhhh.eeeee.....eeeee...................hhhhh........eeee... Sec.struct. author
                 SAPs(SNPs) E------------------------------------------------------------------------------------------------------------------------------------ SAPs(SNPs)
                    PROSITE -----------------------------------------------------------------HBGF_FGF  PDB: B:86-109 -------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.8b  PDB: B:21-57 UniProt: 1-57----------------------------------Exon 1.10f  PDB: B:92-153 UniProt: 92-155 [INCOMPLETE]         Transcript 1 (1)
           Transcript 1 (2) ------------------------------------Exon 1.9b  PDB: B:57-91            -------------------------------------------------------------- Transcript 1 (2)
                 3ojv B  21 GNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVS 153
                                    30        40        50        60        70        80        90       100       110       120       130       140       150   

Chain C from PDB  Type:PROTEIN  Length:213
 aligned with FGFR1_HUMAN | P11362 from UniProtKB/Swiss-Prot  Length:822

    Alignment length:213
                                   156       166       176       186       196       206       216       226       236       246       256       266       276       286       296       306       316       326       336       346       356   
          FGFR1_HUMAN   147 NRMPVAPYWTSPEKMEKKLHAVPAAKTVKFKCPSSGTPNPTLRWLKNGKEFKPDHRIGGYKVRYATWSIIMDSVVPSDKGNYTCIVENEYGSINHTYQLDVVERSPHRPILQAGLPANKTVALGSNVEFMCKVYSDPQPHIQWLKHIEVNGSKIGPDNLPYVQILKTAGVNTTDKEMEVLHLRNVSFEDAGEYTCLAGNSIGLSHHSAWLTVL 359
               SCOP domains d3ojvc1 C:147-249 automated matches                                                                    d3ojvc2 C:250-359 automated matches                                                                            SCOP domains
               CATH domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ....eeeee..hhhhh..eeeee....eeee..eeee...eeeeee..ee.hhhhh....eeehhh.eeee...hhhhheeeeeeeee..eeeeeeeeeeee.......ee.......eee...........ee.....eeeeee.................eeeee.....hhhhhh............eeeeeeee....eeeeeeeeee. Sec.struct. author
             SAPs(SNPs) (1) ------------------S-S------A---S------------S---------------------G----------H---D--------D-T-----P----Q-R-Q---------------D--MG--Y-----R----------------T-----------------------------I-C------C--SV--C-R----------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ------------------------------------------------------------------------------------------S------------W-T----------------------------------------------------------------------------------------------------------- SAPs(SNPs) (2)
                    PROSITE --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
                 Transcript --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript
                 3ojv C 147 NRMPVAPYWTSPEKMEKKLHAVPAAKTVKFKCPSSGTPQPTLRWLKNGKEFKPDHRIGGYKVRYATWSIIMDSVVPSDKGNYTCIVENEYGSINHTYQLDVVERSPHRPILQAGLPANKTVALGSNVEFMCKVYSDPQPHIQWLKHIEVNGSKIGPDNLPYVQILKTAGVNTTDKEMEVLHLRNVSFEDAGEYTCLAGNSIGLSHHSAWLTVL 359
                                   156       166       176       186       196       206       216       226       236       246       256       266       276       286       296       306       316       326       336       346       356   

Chain D from PDB  Type:PROTEIN  Length:213
 aligned with FGFR1_HUMAN | P11362 from UniProtKB/Swiss-Prot  Length:822

    Alignment length:213
                                   156       166       176       186       196       206       216       226       236       246       256       266       276       286       296       306       316       326       336       346       356   
          FGFR1_HUMAN   147 NRMPVAPYWTSPEKMEKKLHAVPAAKTVKFKCPSSGTPNPTLRWLKNGKEFKPDHRIGGYKVRYATWSIIMDSVVPSDKGNYTCIVENEYGSINHTYQLDVVERSPHRPILQAGLPANKTVALGSNVEFMCKVYSDPQPHIQWLKHIEVNGSKIGPDNLPYVQILKTAGVNTTDKEMEVLHLRNVSFEDAGEYTCLAGNSIGLSHHSAWLTVL 359
               SCOP domains d3ojvd1 D:147-249 automated matches                                                                    d3ojvd2 D:250-359 automated matches                                                                            SCOP domains
               CATH domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ....eeeee..hhhhh..eeeee....eeee..eeee...eeeeee..ee.hhhhh....eeehhh.eeee...hhhhheeeeeeeee..eeeeeeeeeeee.......ee.......eee...........ee.....eeeeee.................eeeee.....hhhhhh............eeeeeeee....eeeeeeeeee. Sec.struct. author
             SAPs(SNPs) (1) ------------------S-S------A---S------------S---------------------G----------H---D--------D-T-----P----Q-R-Q---------------D--MG--Y-----R----------------T-----------------------------I-C------C--SV--C-R----------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ------------------------------------------------------------------------------------------S------------W-T----------------------------------------------------------------------------------------------------------- SAPs(SNPs) (2)
                    PROSITE --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
                 Transcript --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript
                 3ojv D 147 NRMPVAPYWTSPEKMEKKLHAVPAAKTVKFKCPSSGTPQPTLRWLKNGKEFKPDHRIGGYKVRYATWSIIMDSVVPSDKGNYTCIVENEYGSINHTYQLDVVERSPHRPILQAGLPANKTVALGSNVEFMCKVYSDPQPHIQWLKHIEVNGSKIGPDNLPYVQILKTAGVNTTDKEMEVLHLRNVSFEDAGEYTCLAGNSIGLSHHSAWLTVL 359
                                   156       166       176       186       196       206       216       226       236       246       256       266       276       286       296       306       316       326       336       346       356   

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (2, 6)

Asymmetric Unit

(-) CATH Domains  (0, 0)

(no "CATH Domain" information available for 3OJV)

(-) Pfam Domains  (0, 0)

(no "Pfam Domain" information available for 3OJV)

(-) Gene Ontology  (133, 156)

Asymmetric Unit(hide GO term definitions)
Chain A,B   (FGF1_HUMAN | P05230)
molecular function
    GO:0016303    1-phosphatidylinositol-3-kinase activity    Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol + ATP = a 1-phosphatidyl-1D-myo-inositol 3-phosphate + ADP + 2 H(+).
    GO:0030544    Hsp70 protein binding    Interacting selectively and non-covalently with Hsp70 proteins, any of a group of heat shock proteins around 70kDa in size.
    GO:0005088    Ras guanyl-nucleotide exchange factor activity    Stimulates the exchange of guanyl nucleotides associated with a GTPase of the Ras superfamily. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase.
    GO:0044548    S100 protein binding    Interacting selectively and non-covalently with a S100 protein. S100 is a small calcium and zinc binding protein produced in astrocytes that is implicated in Alzheimer's disease, Down Syndrome and ALS.
    GO:0005104    fibroblast growth factor receptor binding    Interacting selectively and non-covalently with the fibroblast growth factor receptor (FGFR).
    GO:0008083    growth factor activity    The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.
    GO:0008201    heparin binding    Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
    GO:0005178    integrin binding    Interacting selectively and non-covalently with an integrin.
    GO:0046934    phosphatidylinositol-4,5-bisphosphate 3-kinase activity    Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + ATP = a 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + ADP + 2 H(+).
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0004713    protein tyrosine kinase activity    Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
    GO:0005102    receptor binding    Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
biological process
    GO:0000165    MAPK cascade    An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.
    GO:0000187    activation of MAPK activity    The initiation of the activity of the inactive enzyme MAP kinase (MAPK).
    GO:0032148    activation of protein kinase B activity    Any process that initiates the activity of the inactive enzyme protein kinase B.
    GO:0009653    anatomical structure morphogenesis    The process in which anatomical structures are generated and organized. Morphogenesis pertains to the creation of form.
    GO:0001525    angiogenesis    Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
    GO:0060681    branch elongation involved in ureteric bud branching    The growth of a branch of the ureteric bud along its axis.
    GO:0030154    cell differentiation    The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
    GO:0008283    cell proliferation    The multiplication or reproduction of cells, resulting in the expansion of a cell population.
    GO:0034605    cellular response to heat    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism.
    GO:0008543    fibroblast growth factor receptor signaling pathway    The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.
    GO:0030324    lung development    The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
    GO:0072163    mesonephric epithelium development    The process whose specific outcome is the progression of an epithelium in the mesonephros over time, from its formation to the mature structure. An epithelium is a tissue that covers the internal or external surfaces of an anatomical structure.
    GO:0007275    multicellular organism development    The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).
    GO:0001759    organ induction    The interaction of two or more cells or tissues that causes them to change their fates and specify the development of an organ.
    GO:0018108    peptidyl-tyrosine phosphorylation    The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
    GO:0046854    phosphatidylinositol phosphorylation    The process of introducing one or more phosphate groups into a phosphatidylinositol, any glycerophosphoinositol having one phosphatidyl group esterified to one of the hydroxy groups of inositol.
    GO:0036092    phosphatidylinositol-3-phosphate biosynthetic process    The chemical reactions and pathways resulting in the formation of phosphatidylinositol-3-phosphate, a phosphatidylinositol monophosphate carrying the phosphate group at the 3-position.
    GO:0048015    phosphatidylinositol-mediated signaling    A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives.
    GO:0070374    positive regulation of ERK1 and ERK2 cascade    Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
    GO:0043547    positive regulation of GTPase activity    Any process that activates or increases the activity of a GTPase.
    GO:0043406    positive regulation of MAP kinase activity    Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
    GO:0045766    positive regulation of angiogenesis    Any process that activates or increases angiogenesis.
    GO:0051781    positive regulation of cell division    Any process that activates or increases the frequency, rate or extent of cell division.
    GO:0030335    positive regulation of cell migration    Any process that activates or increases the frequency, rate or extent of cell migration.
    GO:0008284    positive regulation of cell proliferation    Any process that activates or increases the rate or extent of cell proliferation.
    GO:0045542    positive regulation of cholesterol biosynthetic process    Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cholesterol.
    GO:0010595    positive regulation of endothelial cell migration    Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
    GO:0050679    positive regulation of epithelial cell proliferation    Any process that activates or increases the rate or extent of epithelial cell proliferation.
    GO:1902533    positive regulation of intracellular signal transduction    Any process that activates or increases the frequency, rate or extent of intracellular signal transduction.
    GO:0001934    positive regulation of protein phosphorylation    Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
    GO:1903672    positive regulation of sprouting angiogenesis    Any process that activates or increases the frequency, rate or extent of sprouting angiogenesis.
    GO:0045944    positive regulation of transcription from RNA polymerase II promoter    Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
    GO:2000544    regulation of endothelial cell chemotaxis to fibroblast growth factor    Any process that modulates the frequency, rate or extent of endothelial cell chemotaxis to fibroblast growth factor.
    GO:1901509    regulation of endothelial tube morphogenesis    Any process that modulates the frequency, rate or extent of endothelial tube morphogenesis.
    GO:0014066    regulation of phosphatidylinositol 3-kinase signaling    Any process that modulates the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
    GO:0007165    signal transduction    The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
cellular component
    GO:0005938    cell cortex    The region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins.
    GO:0005737    cytoplasm    All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
    GO:0005829    cytosol    The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:0005730    nucleolus    A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome.
    GO:0005654    nucleoplasm    That part of the nuclear content other than the chromosomes or the nucleolus.
    GO:0005634    nucleus    A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
    GO:0005578    proteinaceous extracellular matrix    A layer consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that forms a sheet underlying or overlying cells such as endothelial and epithelial cells. The proteins are secreted by cells in the vicinity. An example of this component is found in Mus musculus.

Chain C,D   (FGFR1_HUMAN | P11362)
molecular function
    GO:0016303    1-phosphatidylinositol-3-kinase activity    Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol + ATP = a 1-phosphatidyl-1D-myo-inositol 3-phosphate + ADP + 2 H(+).
    GO:0005524    ATP binding    Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
    GO:0005088    Ras guanyl-nucleotide exchange factor activity    Stimulates the exchange of guanyl nucleotides associated with a GTPase of the Ras superfamily. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase.
    GO:0050839    cell adhesion molecule binding    Interacting selectively and non-covalently with a cell adhesion molecule.
    GO:0017134    fibroblast growth factor binding    Interacting selectively and non-covalently with a fibroblast growth factor.
    GO:0005007    fibroblast growth factor-activated receptor activity    Combining with a fibroblast growth factor and transmitting the signal across the plasma membrane to initiate a change in cell activity.
    GO:0008201    heparin binding    Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
    GO:0042802    identical protein binding    Interacting selectively and non-covalently with an identical protein or proteins.
    GO:0016301    kinase activity    Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
    GO:0000166    nucleotide binding    Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.
    GO:0046934    phosphatidylinositol-4,5-bisphosphate 3-kinase activity    Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + ATP = a 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + ADP + 2 H(+).
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0032403    protein complex binding    Interacting selectively and non-covalently with any protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0042803    protein homodimerization activity    Interacting selectively and non-covalently with an identical protein to form a homodimer.
    GO:0004672    protein kinase activity    Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
    GO:0004713    protein tyrosine kinase activity    Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
    GO:0016740    transferase activity    Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.
    GO:0004714    transmembrane receptor protein tyrosine kinase activity    Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate.
biological process
    GO:0000165    MAPK cascade    An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.
    GO:0001525    angiogenesis    Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
    GO:0060117    auditory receptor cell development    The process whose specific outcome is the progression of an auditory receptor cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate.
    GO:0048514    blood vessel morphogenesis    The process in which the anatomical structures of blood vessels are generated and organized. The blood vessel is the vasculature carrying blood.
    GO:0007420    brain development    The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.).
    GO:0060445    branching involved in salivary gland morphogenesis    The process in which the branching structure of the salivary gland is generated and organized.
    GO:0048469    cell maturation    A developmental process, independent of morphogenetic (shape) change, that is required for a cell to attain its fully functional state.
    GO:0016477    cell migration    The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
    GO:0021954    central nervous system neuron development    The process whose specific outcome is the progression of a neuron whose cell body is located in the central nervous system, from initial commitment of the cell to a neuronal fate, to the fully functional differentiated neuron.
    GO:0002062    chondrocyte differentiation    The process in which a chondroblast acquires specialized structural and/or functional features of a chondrocyte. A chondrocyte is a polymorphic cell that forms cartilage.
    GO:0043009    chordate embryonic development    The process whose specific outcome is the progression of the embryo over time, from zygote formation through a stage including a notochord and neural tube until birth or egg hatching.
    GO:0030326    embryonic limb morphogenesis    The process, occurring in the embryo, by which the anatomical structures of the limb are generated and organized. A limb is an appendage of an animal used for locomotion or grasping.
    GO:0008543    fibroblast growth factor receptor signaling pathway    The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.
    GO:0035607    fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development    The series of molecular signals generated as a consequence of a fibroblast growth factor-type receptor binding to one of its physiological ligands, which contributes to the progression of the orbitofrontal cortex over time from its initial formation until its mature state.
    GO:0048699    generation of neurons    The process in which nerve cells are generated. This includes the production of neuroblasts and their differentiation into neurons.
    GO:0001701    in utero embryonic development    The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.
    GO:0042472    inner ear morphogenesis    The process in which the anatomical structures of the inner ear are generated and organized. The inner ear is the structure in vertebrates that contains the organs of balance and hearing. It consists of soft hollow sensory structures (the membranous labyrinth) containing fluid (endolymph) surrounded by fluid (perilymph) and encased in a bony cavity (the bony labyrinth). It consists of two chambers, the sacculus and utriculus, from which arise the cochlea and semicircular canals respectively.
    GO:0030324    lung development    The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
    GO:0060484    lung-associated mesenchyme development    The biological process whose specific outcome is the progression of a lung-associated mesenchyme from an initial condition to its mature state. This process begins with the formation of lung-associated mesenchyme and ends with the mature structure. Lung-associated mesenchyme is the tissue made up of loosely connected mesenchymal cells in the lung.
    GO:0048762    mesenchymal cell differentiation    The process in which a relatively unspecialized cell acquires specialized features of a mesenchymal cell. A mesenchymal cell is a loosely associated cell that is part of the connective tissue in an organism. Mesenchymal cells give rise to more mature connective tissue cell types.
    GO:0030901    midbrain development    The process whose specific outcome is the progression of the midbrain over time, from its formation to the mature structure. The midbrain is the middle division of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates, includes a ventral part containing the cerebral peduncles and a dorsal tectum containing the corpora quadrigemina and that surrounds the aqueduct of Sylvius connecting the third and fourth ventricles).
    GO:0042474    middle ear morphogenesis    The process in which the anatomical structures of the middle ear are generated and organized. The middle ear is the air-filled cavity within the skull of vertebrates that lies between the outer ear and the inner ear. It is linked to the pharynx (and therefore to outside air) via the Eustachian tube and in mammals contains the three ear ossicles, which transmit auditory vibrations from the outer ear (via the tympanum) to the inner ear (via the oval window).
    GO:0021837    motogenic signaling involved in postnatal olfactory bulb interneuron migration    The signaling that results in the stimulation of cell movement in the rostral migratory stream.
    GO:0010629    negative regulation of gene expression    Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
    GO:0045668    negative regulation of osteoblast differentiation    Any process that stops, prevents, or reduces the frequency, rate or extent of osteoblast differentiation.
    GO:0000122    negative regulation of transcription from RNA polymerase II promoter    Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter.
    GO:0001764    neuron migration    The characteristic movement of an immature neuron from germinal zones to specific positions where they will reside as they mature.
    GO:0031175    neuron projection development    The process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
    GO:0021769    orbitofrontal cortex development    The progression of the orbitofrontal cortex over time from its initial formation until its mature state. The orbitofrontal cortex is a cerebral cortex region located in the frontal lobe.
    GO:0001759    organ induction    The interaction of two or more cells or tissues that causes them to change their fates and specify the development of an organ.
    GO:0042473    outer ear morphogenesis    The process in which the anatomical structures of the outer ear are generated and organized. The outer ear is the part of the ear external to the tympanum (eardrum). It consists of a tube (the external auditory meatus) that directs sound waves on to the tympanum, and may also include the external pinna, which extends beyond the skull.
    GO:0048339    paraxial mesoderm development    The process whose specific outcome is the progression of the paraxial mesoderm over time, from its formation to the mature structure. The paraxial mesoderm is the mesoderm located bilaterally adjacent to the notochord and neural tube.
    GO:0018108    peptidyl-tyrosine phosphorylation    The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
    GO:0046854    phosphatidylinositol phosphorylation    The process of introducing one or more phosphate groups into a phosphatidylinositol, any glycerophosphoinositol having one phosphatidyl group esterified to one of the hydroxy groups of inositol.
    GO:0036092    phosphatidylinositol-3-phosphate biosynthetic process    The chemical reactions and pathways resulting in the formation of phosphatidylinositol-3-phosphate, a phosphatidylinositol monophosphate carrying the phosphate group at the 3-position.
    GO:0048015    phosphatidylinositol-mediated signaling    A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives.
    GO:0016310    phosphorylation    The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
    GO:0043547    positive regulation of GTPase activity    Any process that activates or increases the activity of a GTPase.
    GO:0043406    positive regulation of MAP kinase activity    Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
    GO:0043410    positive regulation of MAPK cascade    Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade.
    GO:0090080    positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway    The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands resulting in an increase in the rate or frequency of a MAPKKK cascade.
    GO:0060045    positive regulation of cardiac muscle cell proliferation    Any process that activates or increases the frequency, rate or extent of cardiac muscle cell proliferation.
    GO:0045787    positive regulation of cell cycle    Any process that activates or increases the rate or extent of progression through the cell cycle.
    GO:0008284    positive regulation of cell proliferation    Any process that activates or increases the rate or extent of cell proliferation.
    GO:2000546    positive regulation of endothelial cell chemotaxis to fibroblast growth factor    Any process that activates or increases the frequency, rate or extent of endothelial cell chemotaxis to fibroblast growth factor.
    GO:0002053    positive regulation of mesenchymal cell proliferation    The process of activating or increasing the rate or extent of mesenchymal cell proliferation. Mesenchymal cells are loosely organized embryonic cells.
    GO:0045666    positive regulation of neuron differentiation    Any process that activates or increases the frequency, rate or extent of neuron differentiation.
    GO:0010976    positive regulation of neuron projection development    Any process that increases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
    GO:0014068    positive regulation of phosphatidylinositol 3-kinase signaling    Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
    GO:0010863    positive regulation of phospholipase C activity    Any process that increases the rate of phospholipase C activity.
    GO:0010518    positive regulation of phospholipase activity    Any process that increases the frequency, rate or extent of phospholipase activity, the hydrolysis of a phospholipid.
    GO:0046777    protein autophosphorylation    The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
    GO:0006468    protein phosphorylation    The process of introducing a phosphate group on to a protein.
    GO:0060665    regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling    Any process that modulates the rate, frequency, or extent of branching involved in salivary gland morphogenesis as a result of signals being generated by the mesenchyme and received and interpreted by the salivary gland epithelium.
    GO:0045595    regulation of cell differentiation    Any process that modulates the frequency, rate or extent of cell differentiation, the process in which relatively unspecialized cells acquire specialized structural and functional features.
    GO:0042127    regulation of cell proliferation    Any process that modulates the frequency, rate or extent of cell proliferation.
    GO:2001239    regulation of extrinsic apoptotic signaling pathway in absence of ligand    Any process that modulates the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand.
    GO:0010468    regulation of gene expression    Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
    GO:0048378    regulation of lateral mesodermal cell fate specification    Any process that modulates the frequency, rate or extent of lateral mesoderm cell fate specification.
    GO:0014066    regulation of phosphatidylinositol 3-kinase signaling    Any process that modulates the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
    GO:0051930    regulation of sensory perception of pain    Any process that modulates the frequency, rate or extent of the sensory perception of pain, the series of events required for an organism to receive a painful stimulus, convert it to a molecular signal, and recognize and characterize the signal.
    GO:0072091    regulation of stem cell proliferation    Any process that modulates the frequency, rate or extent of stem cell proliferation. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells.
    GO:0006355    regulation of transcription, DNA-templated    Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
    GO:0007435    salivary gland morphogenesis    The process in which the anatomical structures of the salivary gland are generated and organized.
    GO:0007605    sensory perception of sound    The series of events required for an organism to receive an auditory stimulus, convert it to a molecular signal, and recognize and characterize the signal. Sonic stimuli are detected in the form of vibrations and are processed to form a sound.
    GO:0001501    skeletal system development    The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
    GO:0048705    skeletal system morphogenesis    The process in which the anatomical structures of the skeleton are generated and organized.
    GO:0019827    stem cell population maintenance    The process by which an organism or tissue maintains a population of stem cells of a single type. This can be achieved by a number of mechanisms: stem cell asymmetric division maintains stem cell numbers; stem cell symmetric division increases them; maintenance of a stem cell niche maintains the conditions for commitment to the stem cell fate for some types of stem cell; stem cells may arise de novo from other cell types.
    GO:0006351    transcription, DNA-templated    The cellular synthesis of RNA on a template of DNA.
    GO:0001657    ureteric bud development    The process whose specific outcome is the progression of the ureteric bud over time, from its formation to the mature structure.
    GO:0021847    ventricular zone neuroblast division    The proliferation of neuroblasts in the ventricular zone of the cerebral cortex. The neuronal progenitors of these cells will migrate radially.
cellular component
    GO:0005737    cytoplasm    All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
    GO:0031410    cytoplasmic vesicle    A vesicle found in the cytoplasm of a cell.
    GO:0005829    cytosol    The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0016021    integral component of membrane    The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0005887    integral component of plasma membrane    The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0005634    nucleus    A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
    GO:0043235    receptor complex    Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.

 Visualization

(-) Interactive Views

Asymmetric Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    IDS  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    SGN  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    UAP  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
    AC5  [ RasMol ]  +environment [ RasMol ]
    AC6  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    Leu C:261 - Pro C:262   [ RasMol ]  
    Leu D:261 - Pro D:262   [ RasMol ]  
    Thr C:183 - Pro C:184   [ RasMol ]  
    Thr D:183 - Pro D:184   [ RasMol ]  
 
Biological Units
  Complete Structure
    Biological Unit 1  [ Jena3D ]
    Biological Unit 2  [ Jena3D ]

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  3ojv
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  FGF1_HUMAN | P05230
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
  FGFR1_HUMAN | P11362
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  2.7.10.1
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  101600
    Disease InformationOMIM
  147950
    Disease InformationOMIM
  166250
    Disease InformationOMIM
  190440
    Disease InformationOMIM
  615465
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  FGF1_HUMAN | P05230
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)
  FGFR1_HUMAN | P11362
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        FGF1_HUMAN | P052301axm 1djs 1dzc 1dzd 1e0o 1evt 1hkn 1jqz 1jt3 1jt4 1jt5 1jt7 1jtc 1jy0 1k5u 1k5v 1m16 1nzk 1p63 1pzz 1q03 1q04 1qct 1rg8 1rml 1ry7 1yto 1z2v 1z4s 2afg 2aqz 2axm 2erm 2hw9 2hwa 2hwm 2hz9 2k43 2k4a 2k8r 2ki4 2ki6 2ntd 2q9x 2rq9 3b9u 3ba4 3ba5 3ba7 3bad 3bag 3bah 3bao 3baq 3bau 3bav 3bb2 3cqa 3crg 3crh 3cri 3cu1 3fgm 3fj8 3fj9 3fja 3fjb 3fjc 3fjd 3fje 3fjf 3fjh 3fji 3fjj 3fjk 3hom 3jut 3k1x 3o3q 3oj2 3ojm 3ud7 3ud8 3ud9 3uda 4j23 4q91 4q9g 4q9p 4qal 4qbc 4qbv 4qc4 4qo3 4xki 4yol
        FGFR1_HUMAN | P113621agw 1cvs 1evt 1fgi 1fgk 1fq9 1xr0 2cr3 2fgi 3c4f 3dpk 3gqi 3gql 3js2 3krj 3krl 3kxx 3ky2 3rhx 3tt0 4f63 4f64 4f65 4nk9 4nka 4nks 4rwi 4rwj 4rwk 4rwl 4uwb 4uwc 4uwy 4v01 4v04 4v05 4wun 4zsa 5a46 5a4c 5am6 5am7 5b7v 5ew8 5flf 5uq0 5ur1 5vnd

(-) Related Entries Specified in the PDB File

1djs 1evt 1ry7 3oj2 3ojm